Clinical Trials Directory

Trials / Unknown

UnknownNCT03552952

Development of Preterm Infant Gut Microbiome

Status
Unknown
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
Rambam Health Care Campus · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

This study aims to explore the developmental of the gut microbiome in preterm infants as they grow and mature

Detailed description

Preterm birth, defined as childbirth occurring at less than 37 completed weeks, is a major determinant of neonatal mortality and morbidity and has long-term adverse consequences for health. The human microbiome is the collective genome of the immense ecosystem of trillions of microbes and is considered to have a coevolved relationship with the immune system and fundamental roles in multiple aspects of human physiology. Little is known about the developmental of the gut microbiome in preterm infants as they grow and mature. One hundred premature infants born in Rambam healthcare campus in Haifa, Israel, will be recruited to the study and 100 term healthy infants will be recruited as controls. Infants born before 24 weeks of gestation or have birth weights of less than 400 g and infants with severe congenital anomalies will be excluded from the study. Fecal samples will be collected during the hospital stay and in follow-up visits. Blood samples will be taken during the hospital stay. The investigators will analyze the data from this clinical cohort using computational and experimental approaches for extracting novel information on microbiome composition and development, gene function, metabolic pathways and metabolite production.

Conditions

Interventions

TypeNameDescription
OTHERNo interventionNo intervention

Timeline

Start date
2018-03-08
Primary completion
2025-07-01
Completion
2025-07-01
First posted
2018-06-12
Last updated
2020-07-22

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT03552952. Inclusion in this directory is not an endorsement.